SI1074558T1 - Process for the preparation of mometasone furoate - Google Patents

Process for the preparation of mometasone furoate

Info

Publication number
SI1074558T1
SI1074558T1 SI9930173T SI9930173T SI1074558T1 SI 1074558 T1 SI1074558 T1 SI 1074558T1 SI 9930173 T SI9930173 T SI 9930173T SI 9930173 T SI9930173 T SI 9930173T SI 1074558 T1 SI1074558 T1 SI 1074558T1
Authority
SI
Slovenia
Prior art keywords
preparation
mometasone furoate
mometasone
furoate
free
Prior art date
Application number
SI9930173T
Other languages
English (en)
Slovenian (sl)
Inventor
William Dr. Heggie
Joao Bandarra
Original Assignee
Hovione Inter Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Inter Ltd. filed Critical Hovione Inter Ltd.
Publication of SI1074558T1 publication Critical patent/SI1074558T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI9930173T 1999-08-02 1999-10-25 Process for the preparation of mometasone furoate SI1074558T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT102343A PT102343B (pt) 1999-08-02 1999-08-02 Processo para a preparacao de furoato mometasona

Publications (1)

Publication Number Publication Date
SI1074558T1 true SI1074558T1 (en) 2003-04-30

Family

ID=20085881

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930173T SI1074558T1 (en) 1999-08-02 1999-10-25 Process for the preparation of mometasone furoate

Country Status (22)

Country Link
US (1) US6177560B1 (xx)
EP (1) EP1074558B1 (xx)
JP (1) JP3746174B2 (xx)
KR (1) KR100640066B1 (xx)
CN (1) CN1149222C (xx)
AT (1) ATE229970T1 (xx)
AU (1) AU765592B2 (xx)
CA (1) CA2295455C (xx)
DE (1) DE69904585T2 (xx)
DK (1) DK1074558T3 (xx)
ES (1) ES2189354T3 (xx)
HR (1) HRP990341B1 (xx)
HU (1) HU227494B1 (xx)
IL (1) IL133752A (xx)
NO (1) NO321154B1 (xx)
NZ (1) NZ500555A (xx)
PL (1) PL191103B1 (xx)
PT (1) PT102343B (xx)
RU (1) RU2208616C2 (xx)
SI (1) SI1074558T1 (xx)
UA (1) UA60333C2 (xx)
ZA (1) ZA996758B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
EP1790754A1 (de) * 2005-11-24 2007-05-30 Siemens Aktiengesellschaft Schichtsystem mit Gadolinium-Mischkristall-Pyrochlorphase
US8021742B2 (en) * 2006-12-15 2011-09-20 Siemens Energy, Inc. Impact resistant thermal barrier coating system
PL3111926T3 (pl) 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje, sposoby i układy do dostarczania dwóch lub większej liczby środków czynnych do układu oddechowego
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PT105139B (pt) * 2010-06-01 2013-01-29 Hovione Farmaciencia S A Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
MX2015016058A (es) 2013-05-22 2016-12-20 Pearl Therapeutics Inc Composiciones, metodos y sistemas para el suministro por via respiratoria de tres o mas agentes activos.
CN105481933B (zh) * 2015-12-25 2017-09-19 山东京卫制药有限公司 一种合成糠酸莫米松的方法
CN105566437B (zh) * 2015-12-30 2018-07-20 山东京卫制药有限公司 一种8dm衍生物及利用其合成糠酸莫米松的方法
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
WO2023283441A1 (en) 2021-07-09 2023-01-12 Astrazeneca Pharmaceuticals Lp Compositions, methods and systems for aerosol drug delivery
WO2023119093A1 (en) 2021-12-20 2023-06-29 Astrazeneca Ab Compositions, methods and systems for aerosol drug delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE8790T1 (de) * 1981-02-02 1984-08-15 Schering Corporation Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
PT923599E (pt) * 1996-06-28 2002-06-28 Schering Corp Processo para a preparacao de 17-esteres de 9alfa,21-di-halopregnano-11beta,17alfadiol-20-onas
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones

Also Published As

Publication number Publication date
PT102343A (pt) 2001-02-28
HUP9903747A2 (hu) 2001-05-28
CA2295455C (en) 2008-03-25
US6177560B1 (en) 2001-01-23
CN1149222C (zh) 2004-05-12
IL133752A0 (en) 2001-04-30
HU227494B1 (en) 2011-07-28
EP1074558A1 (en) 2001-02-07
ES2189354T3 (es) 2003-07-01
NO995225D0 (no) 1999-10-26
JP2001048897A (ja) 2001-02-20
PL191103B1 (pl) 2006-03-31
HUP9903747A3 (en) 2001-07-30
KR100640066B1 (ko) 2006-10-31
HU9903747D0 (en) 1999-12-28
PT102343B (pt) 2003-11-28
CN1282744A (zh) 2001-02-07
NO995225L (no) 2001-02-05
NO321154B1 (no) 2006-03-27
HRP990341B1 (en) 2003-10-31
DE69904585D1 (de) 2003-01-30
ATE229970T1 (de) 2003-01-15
HRP990341A2 (en) 2001-04-30
KR20010020094A (ko) 2001-03-15
IL133752A (en) 2004-02-19
UA60333C2 (uk) 2003-10-15
EP1074558B1 (en) 2002-12-18
JP3746174B2 (ja) 2006-02-15
AU765592B2 (en) 2003-09-25
RU2208616C2 (ru) 2003-07-20
AU5602499A (en) 2001-02-08
ZA996758B (en) 2000-08-30
DK1074558T3 (da) 2003-04-07
DE69904585T2 (de) 2003-05-15
CA2295455A1 (en) 2001-02-02
PL336452A1 (en) 2001-02-12
NZ500555A (en) 2000-11-24

Similar Documents

Publication Publication Date Title
AU6675400A (en) Software code protection by obscuring its data-driven form
ES2134847T3 (es) Derivados de taxol.
ZA996758B (en) Process for the preparation of mometasone furoate.
HK1028769A1 (en) 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
EP1401433A4 (en) CONSTANTLY CONFORMING ANALOGUES AS AGENTS AGAINST DIABETES AND AGAINST OBESITY, AND ASSOCIATED METHOD
WO2002032898A3 (de) Neue anticholinergika, verfahren zu deren herstellung und deren verwendung als arzneimittel
IL147220A0 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
AU6093296A (en) Infectious dengue 2 virus pdk-53 as quadravalent vaccine
DK0717041T3 (da) Krystallinske paclitaxel-hydrater
WO2001045678A3 (de) Arzneimittel, verfahren zu dessen herstellung und dessen verwendung
ZA200201816B (en) A vaccine composition and method of using the same.
AP9400621A0 (en) Influenza vaccine compositions
AU1951495A (en) Alphavirus rna as carrier for vaccines
NZ295238A (en) Immunogenic compositions characterised by the carrier being a hydrophobic solvent in the absence of a hydrophilic phase
IL134308A0 (en) A universally applicable blood plasma
GB9420114D0 (en) Substituted cyclic derivatives as novel antidegenerative agents
DE4493718T1 (de) Abbaubare Succinsäurederivatchelanten, Verwendungen und Zusammensetzungen davon
WO1997013776A3 (fr) Nouveaux derives amines de 2', 3' didesoxyglycosides d'epipodophyllotoxine, leur procede de preparation, leur utilisation comme medicament et leur utilisation destinee aux traitements anticancereux
AU7773900A (en) Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds
FI945414A0 (fi) Menetelmä N,N-disubstituoidun aminofenolin valmistamiseksi
IT1294969B1 (it) Composizione immunogena per hiv